*0011007714
*00520190130100733.0
*007ta
*008051102s2004    xx#           000 u eng d
*00901057caa a2200253 c 4500
*019  $bk
*035  $a(EXLNZ-47BIBSYS_NETWORK)990520217854702201
*035  $a(NO-TrBIB)052021785
*035  $a052021785-47bibsys_network
*040  $aNO-TrBIB$bnob$ekatreg
*24500$aHow prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure?$cMorten Svensson...[et al.]
*260  $c2004
*300  $aS. 297-303
*500  $aØvrige forfattere: Finn Gustafsson, Søren Galatius, Per R. Hildebrandt, Dan Atar
*653  $aaker$auniversitetssykehus$_87030900
*7001 $aAtar, Dan$0(NO-TrBIB)4072770$_124584500
*7001 $aGalatius, Søren$0(NO-TrBIB)3076081$_124584600
*7001 $aGustafsson, Finn$0(NO-TrBIB)5085129$_124584700
*7001 $aHildebrandt, Per$0(NO-TrBIB)90530968$_124584800
*7001 $aSvensson, Morten$0(NO-TrBIB)5087905$_124585400
*7730 $tJournal of cardiac failure (trykt utg.).$dNaperville, Ill. : Churchill Livingstone$g10(2004)4$x1071-9164$w999608368454702201$w(NO-LaBS)898584(tnr)
*901  $a80
*999  $aoai:nb.bibsys.no:990520217854702202$b2021-10-31T03:13:54Z$z990520217854702202
^